Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118388) titled 'Retrospective Study on Gold Nanocomposites for NMIBC Bladder Perfusion Diagnosis and Treatment' on Feb. 4.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
Bladder cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Trail group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=302490
Disclaimer: Curated by HT Syndication....